Latest filing published 03 Feb 2026 for Elicio Therapeutics, Inc..
This profile gathers the share dealings of Peter DeMuth in Elicio Therapeutics, Inc. We count 3 filings; the first trade dates from 16 December 2024 and the latest from 2 February 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 3 February 2026, reports a share grant in Elicio Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations